Pediatrics Medicine Market Report 2024 (Global Edition)

Global Pediatrics Medicine Market Report 2024 Market Size Split by Type (Oral, Topical, Others), by Drug Type (Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovasc...

Pediatrics Medicine Market Report Description

We have various report editions of Pediatrics Medicine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Pediatrics Medicine Market Insights Video

Competitive Landscape of the Pediatrics Medicine Market

In order to increase their market share of the global pediatric pharmaceuticals market, the main companies are emphasizing growth strategies, including mergers and acquisitions, new product approvals, and product developments. The extension of medication use by pediatric consumers is significantly influenced by regulatory authority approvals.

In April 2024, Cipla, Inc. has introduced a new pediatric antibiotic syrup that is specifically designed to treat bacterial infections in children. The objective of this product is to provide a treatment option that is both effective and appealing to youthful patients. (Source: https://www.cipla.com/press-releases-statements/orchid-pharma-partners-with-cipla-to-launch-antibiotic-cefepime) In June 2024, Biomarin Pharmaceutical, Inc. has introduced a novel gene therapy to address a rare pediatric metabolic disorder. This therapy represents a substantial improvement in the treatment options available to adolescent patients with this condition. (Source: https://investors.biomarin.com/news/news-details/2022/First-Gene-Therapy-for-Adults-with-Severe-Hemophilia-A-BioMarins-ROCTAVIAN-valoctocogene-roxaparvovec-Approved-by-European-Commission-EC-08-24-2022/) In March 2024, Gilead Sciences, Inc. has developed a pediatric version of their antiviral medication, Veklury, which is intended for children who are suffering from severe COVID-19. The objective of this novel product is to enhance the prognosis of pediatric patients who are afflicted by the virus. (Source: https://www.gilead.com/news/news-details/2020/us-food-and-drug-administration-approves-gileads-antiviral-veklury-remdesivir-for-treatment-of-covid19)

Top Companies Market Share in Pediatrics Medicine Industry: (In no particular order of Rank)

• F. Hoffman-La Roche Ltd
• Pfizer Inc.
• GlaxoSmithKline plc.
• Merck Co.Ltd.
• Sanofi S.A.
• Eli Lilly & Company
• Lupin
• Novartis A.G
• Abbott Laboratories
• Heron Therapeutics Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Pediatrics Medicine Market

Which Region Dominates the Pediatrics Medicine Market in 2024?

According to Cognitive Market Research, North America currently dominates the Pediatrics Medicines market, and the region is expected to have significant growth during the projected period. Due to the significant increase in the number of pediatric patient cases, including children with cerebral palsy, muscular atrophy, respiratory disorders, and autoimmune disorders, as well as the rapid adoption of advanced technologies in the United States, which controls the majority of the North American market's revenue.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The region is the leader in the related field due to the growing demand for pediatric medications, the improvement of healthcare access, and the escalating pediatric population. Additionally, the market position is further impacted by the region's escalating infectious diseases among children and the greater number of medications approved by regulatory authorities during the forecast period.

The current report Scope analyzes Pediatrics Medicine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Pediatrics Medicine

According to Cognitive Market Research, the global Pediatrics Medicine market size was estimated at USD 131542.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 52616.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Pediatrics Medicine market with a market size of USD 41514.72 million in 2024 and is anticipated to grow at a CAGR of 11.2% during the projected period. The U.S. market's improvements in medical technology and a significant number of pediatric diseases.
• The Canada Pediatrics Medicine market had a market share of USD 6314.03 million in 2024 and is anticipated to grow at a CAGR of 12.2% during the projected period. Canada’s expanding healthcare expenditures and an intensifying emphasis on the health and well-being of children.
• The Mexico Pediatrics Medicine market is anticipated to see growth at a CAGR of 11.9% during the projected period, with a market size of USD 4788.14 million in 2024.

Europe Pediatrics Medicine

According to Cognitive Market Research, the global Pediatrics Medicine market size was estimated at USD 131542.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 39462.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.7% from 2024 to 2031.

• The United Kingdom Pediatrics Medicine market had a market share of USD 6629.73 million in 2024 and is anticipated to grow at a CAGR of 12.5% during the projected period. In the UK, the growth is driven because of heightened government investment in pediatric healthcare and the advancement of innovative pediatric medicines and equipment.
• The France Pediatrics Medicine market is anticipated to see growth at a CAGR of 10.9% during the projected period, with a market size of USD 3630.56 million in 2024.
• According to Cognitive Market Research, the German Pediatrics Medicine market size was valued at USD 7813.61 million in 2024 and is anticipated to grow at a CAGR of 11.9% during the projected period. In Germany, a significant emphasis on the advancement of medical research and development, as well as a high incidence of chronic diseases in minors.
• The Italy Pediatrics Medicine market is anticipated to see growth at a CAGR of 11.1% during the projected period, with a market size of USD 3393.79 million in 2024.
• The Russia Pediatrics Medicine market is anticipated to see growth at a CAGR of 10.7% during the projected period, with a market size of USD 6116.71million in 2024.
• The Spain Pediatrics Medicine market is anticipated to see growth at a CAGR of 10.8% during the projected period with a market size of USD 3235.94 million in 2024
• The Luxembourg Pediatrics Medicine market is anticipated to see growth at a CAGR of 11.8% during the projected period, with a market size of USD 1223.34 million in 2024.
• The Portugal Pediatrics Medicine market is anticipated to see growth at a CAGR of 11.5% during the projected period, with a market size of USD 828.72 million in 2024.
• The Greece Pediatrics Medicine market is anticipated to see growth at a CAGR of 12.0% during the projected period, with a market size of USD 473.55 million in 2024.
• The Rest of Europe's Pediatrics Medicine market is anticipated to see growth at a CAGR of 10.4% during the projected period, with a market size of USD 6116.71 million in 2024.

Asia Pacific Pediatrics Medicine

According to Cognitive Market Research, the global Pediatrics Medicine market size was estimated at USD 131542.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 30254.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.2% from 2024 to 2031.

• According to Cognitive Market Research, the China Pediatrics Medicine market size was valued at USD 13614.62 million in 2024 and is anticipated to grow at a CAGR of 14.7% during the projected period. Pediatrics Medicine surged in China due to a growing pediatric population and a rise in healthcare investments.
• The Japan Pediatrics Medicine market is anticipated to see growth at a CAGR of 13.7% during the projected period, with a market size of USD 4175.15 million in 2024.
• The India Pediatrics Medicine market had a market share of USD 3630.56 million in 2024 and is anticipated to grow at a CAGR of 17.0% during the projected period. India's rising government initiatives.
• The South Korean Pediatrics Medicine market is anticipated to see growth at a CAGR of 14.3% during the projected period, with a market size of USD 3025.47 million in 2024.
• The Australian Pediatrics Medicine market is anticipated to see growth at a CAGR of 14.9% during the projected period, with a market size of USD 1573.24 million in 2024.
• The South East Asia Pediatrics Medicine market is anticipated to see growth at a CAGR of 16.2% during the projected period, with a market size of USD 2087.57 million in 2024.
• The Rest of Asia Pacific Pediatrics Medicine market is anticipated to see growth at a CAGR of 15.0% during the projected period, with a market size of USD 2148.08 million in 2024.

South America Pediatrics Medicine

According to Cognitive Market Research, the global Pediatrics Medicine market size was estimated at USD 131542.2 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 6577.11 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Pediatrics Medicine market size was valued at USD 2815.0 million in 2024 and is anticipated to grow at a CAGR of 13.2% during the projected period. Pediatrics Medicines flourished in Brazil due to increasing public awareness of pediatric healthcare and the advancements in medical technology.
• Argentina's Pediatrics Medicine market had a market share of USD 1104.95 million in 2024 and is anticipated to grow at a CAGR of 13.5% during the projected period. Argentina's rising initiatives by the government to enhance the health of children.
• Colombia Pediatrics Medicine market is anticipated to see growth at a CAGR of 12.4% during the projected period, with a market size of USD 585.36 million in 2024.
• Peru Pediatrics Medicine market is anticipated to see growth at a CAGR of 12.8% during the projected period, with a market size of USD 539.32 million in 2024.
• Chile Pediatrics Medicine market is anticipated to see growth at a CAGR of 12.9% during the projected period, with a market size of USD 473.55 million in 2024.
• The Rest of Latin America's Pediatrics Medicine market is anticipated to see growth at a CAGR of 11.7% during the projected period, with a market size of USD 1058.91 million in 2024.

Middle East and Africa Pediatrics Medicine

According to Cognitive Market Research, the global Pediatrics Medicine market size was estimated at USD 131542.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 2630.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.9% from 2024 to 2031.

• The GCC Countries Pediatrics Medicine market is anticipated to see growth at a CAGR of 13.7% during the projected period, with a market size of USD 1126.00 million in 2024. Pediatrics Medicine sales flourish due to the rising expenditures in healthcare infrastructure and the increasing prevalence of chronic pediatric diseases.
• The Egypt Pediatrics Medicine market is anticipated to see growth at a CAGR of 13.2% during the projected period, with a market size of USD 276.24 million in 2024.
• The South Africa Pediatrics Medicine market is anticipated to see growth at a CAGR of 13.9% during the projected period, with a market size of USD 415.67 million in 2024. Pediatrics Medicine sales flourished in South Africa due to developments in medical technology and an increasing recognition of the healthcare requirements of children.
• The Turkey Pediatrics Medicine market is anticipated to see growth at a CAGR of 12.4% during the projected period, with a market size of USD 226.25 million in 2024.
• The Nigeria Pediatrics Medicine market is anticipated to see growth at a CAGR of 12.0% during the projected period, with a market size of USD 276.24 million in 2024.
• The Rest of the MEA Pediatrics Medicine market is anticipated to see growth at a CAGR of 11.9% during the projected period, with a market size of USD 310.44 million in 2024.

Pediatrics Medicine Market Analysis

Pediatrics Medicine Market Type Segment Analysis

According to Cognitive Market Research, Oral Pediatrics Medicines are likely to dominate the Pediatrics Medicine Market over the forecast period. Due to its non-invasive nature and reduced risk of suffering, oral administration of medications is the preferred method of administration for pediatric patients. In addition, this method is much more pleasant for parents to administer medicine, which results in enhanced compliance with the medication administered through this route.

The Topical is the fastest-growing segment in the Pediatrics Medicine Market. This is a result of the simplicity of administration to a child, as well as the low risk of adverse reactions and drug interactions. Furthermore, the growth of this segment in the Pediatrics medication market is influenced by the low cost, high concentration of antibiotics, and the fact that a minimal quantity of drug is used when applied to the afflicted area.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Pediatrics Medicine Industry. Request a Free Sample PDF!

Pediatrics Medicine Market Drug Type Segment Analysis

According to Cognitive Market Research, the Respiratory Disorder Drugs segment holds the largest share of the market, because children have a poorer immune system, and since pollution levels are increasing, in addition to the fact that they are exposed to allergens, which leads to persistent respiratory diseases.

In the Pediatrics Medicine Market, the Autoimmune Disorder Drugs has been expanding at a rapid pace. The increasing incidence of genetic illnesses, malignancies, and cystic fibrosis, which give incentives in order to support and aid in the creation of medications for such uncommon autoimmune conditions, is responsible for this phenomenon.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion